The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1411
March 4, 2013
View Complete Issue         Table of Contents 2019 
Misoprostol for Miscarriage
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Misoprostol for Miscarriage
March 4, 2013 (Issue: 1411)
Misoprostol (Cytotec, and generics), a prostaglandin E1 analog FDA-approved for prevention of NSAID-induced gastric ulcers and, when taken with mifepristone (Mifeprex), for termination of early intrauterine pregnancy, has also been used...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Misoprostol for Miscarriage
Article code: 1411b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.